Daptomycin-rifampin for a recurrent MRSA joint infection unresponsive to vancomycin-based therapy

被引:32
作者
Burns, CA [1 ]
机构
[1] Ocala Reg Med Ctr, Ocala, FL 34478 USA
关键词
D O I
10.1080/00365540500277292
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A 54-y-old morbidly obese male presented with methicillin-resistant Staphylococcus aureus ( MRSA) bacteremia secondary to chronic right hip arthroplasty infection. Bacteremia persisted despite prolonged vancomycin-based therapy ( MIC <= 1 mu g/ml) and prosthetic removal. Adding daptomycin-rifampin resolved bacteremia within 48 h; hip cultures remained negative post-discharge. This case describes alternative treatment for chronic MRSA infections.
引用
收藏
页码:133 / 136
页数:4
相关论文
共 18 条
  • [1] Trends in the treatment of orthopaedic prosthetic infections[J]. Bernard, L;Hoffmeyer, P;Assal, M;Vaudaux, P;Schrenzel, J;Lew, D. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004(02)
  • [2] *CDC, NATL NOS INF SURV SY
  • [3] Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations[J]. Cha, R;Brown, WJ;Rybak, MJ. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003(12)
  • [4] Antibiotic treatment of Gram-positive bone and joint infections[J]. Darley, ESR;MacGowan, AP. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004(06)
  • [5] Severe myopathy and possible hepatotoxicity related to daptomycin[J]. Echevarria, K;Datta, P;Cadena, J;Lewis, JS. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005(04)
  • [6] In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants[J]. Fluit, AC;Schmitz, FJ;Verhoef, J;Milatovic, D. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004(03)
  • [7] Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization[J]. Huang, SS;Platt, R. CLINICAL INFECTIOUS DISEASES, 2003(03)
  • [8] Prosthetic joint infections: Bane of orthopedists, challenge for infectious disease specialists[J]. Lentino, JR. CLINICAL INFECTIOUS DISEASES, 2003(09)
  • [9] SLOW RESPONSE TO VANCOMYCIN OR VANCOMYCIN PLUS RIFAMPIN IN METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS[J]. LEVINE, DP;FROMM, BS;REDDY, BR. ANNALS OF INTERNAL MEDICINE, 1991(09)
  • [10] COMPARATIVE-EVALUATION OF DAPTOMYCIN (LY146032) AND VANCOMYCIN IN THE TREATMENT OF EXPERIMENTAL METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS OSTEOMYELITIS IN RABBITS[J]. MADER, JT;ADAMS, K. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989(05)